In vivo reprogramming drives Kras-induced cancer development.
Shibata H, Komura S, Yamada Y, Sankoda N, Tanaka A, Ukai T, Kabata M, Sakurai S, Kuze B, Woltjen K, Haga H, Ito Y, Kawaguchi Y, Yamamoto T, Yamada Y.
Shibata H, et al. Among authors: sankoda n.
Nat Commun. 2018 May 25;9(1):2081. doi: 10.1038/s41467-018-04449-5.
Nat Commun. 2018.
PMID: 29802314
Free PMC article.